LSTA
Price
$1.26
Change
-$0.21 (-14.29%)
Updated
Oct 5 closing price
Capitalization
16.21M
30 days until earnings call
Intraday BUY SELL Signals
PYPD
Price
$5.20
Change
+$0.01 (+0.19%)
Updated
Oct 5 closing price
Capitalization
107.86M
36 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LSTA vs PYPD

LSTA vs PYPD Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
LSTA vs. PYPD commentary
Oct 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LSTA is a Buy and PYPD is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
LSTA vs PYPD: Fundamental Ratings
LSTA
PYPD
OUTLOOK RATING
1..100
9385
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
64
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
9042
P/E GROWTH RATING
1..100
10043
SEASONALITY SCORE
1..100
850

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LSTA's Valuation (40) in the null industry is in the same range as PYPD (64). This means that LSTA’s stock grew similarly to PYPD’s over the last 12 months.

LSTA's Profit vs Risk Rating (100) in the null industry is in the same range as PYPD (100). This means that LSTA’s stock grew similarly to PYPD’s over the last 12 months.

LSTA's SMR Rating (99) in the null industry is in the same range as PYPD (100). This means that LSTA’s stock grew similarly to PYPD’s over the last 12 months.

PYPD's Price Growth Rating (42) in the null industry is somewhat better than the same rating for LSTA (90). This means that PYPD’s stock grew somewhat faster than LSTA’s over the last 12 months.

PYPD's P/E Growth Rating (43) in the null industry is somewhat better than the same rating for LSTA (100). This means that PYPD’s stock grew somewhat faster than LSTA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LSTAPYPD
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 11 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
88%
COMPARISON
Comparison
Oct 06, 2026
Stock price -- (LSTA: $1.26 vs. PYPD: $5.20)
Brand notoriety: LSTA and PYPD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LSTA: 24% vs. PYPD: 83%
Market capitalization -- LSTA: $16.21M vs. PYPD: $107.86M
LSTA [@Biotechnology] is valued at $16.21M. PYPD’s [@Biotechnology] market capitalization is $107.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LSTA’s FA Score shows that 0 FA rating(s) are green while PYPD’s FA Score has 0 green FA rating(s).

  • LSTA’s FA Score: 0 green, 5 red.
  • PYPD’s FA Score: 0 green, 5 red.
According to our system of comparison, PYPD is a better buy in the long-term than LSTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LSTA’s TA Score shows that 5 TA indicator(s) are bullish while PYPD’s TA Score has 2 bullish TA indicator(s).

  • LSTA’s TA Score: 5 bullish, 4 bearish.
  • PYPD’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, LSTA is a better buy in the short-term than PYPD.

Price Growth

LSTA (@Biotechnology) experienced а -16.00% price change this week, while PYPD (@Biotechnology) price change was -2.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.37%. For the same industry, the average monthly price growth was -13.88%, and the average quarterly price growth was -3.26%.

Reported Earning Dates

LSTA is expected to report earnings on Nov 05, 2026.

PYPD is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (-3.37% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
LSTA
Daily Signal:
Gain/Loss:
PYPD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LZ5.870.27
+4.82%
LegalZoom.com
BOX35.340.85
+2.46%
BOX
PASW0.13N/A
+1.84%
Ping An Biomedical Co. Ltd.
DHX4.81N/A
N/A
DHI Group
UAL110.00-2.51
-2.23%
United Airlines Holdings

LSTA and

Correlation & Price change

A.I.dvisor tells us that LSTA and PYPD have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LSTA and PYPD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LSTA
1D Price
Change %
LSTA100%
-14.29%
PYPD - LSTA
30%
Poorly correlated
+0.19%
RAIN - LSTA
29%
Poorly correlated
-1.44%
MLEC - LSTA
27%
Poorly correlated
+0.83%
ASND - LSTA
26%
Poorly correlated
+0.07%
AMLX - LSTA
25%
Poorly correlated
-0.04%
More

PYPD and

Correlation & Price change

A.I.dvisor tells us that PYPD and LSTA have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PYPD and LSTA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYPD
1D Price
Change %
PYPD100%
+0.19%
LSTA - PYPD
29%
Poorly correlated
-14.29%
AMLX - PYPD
29%
Poorly correlated
-0.04%
SYRE - PYPD
29%
Poorly correlated
-0.50%
INM - PYPD
28%
Poorly correlated
+0.19%
FENC - PYPD
28%
Poorly correlated
+4.12%
More